New Partnership Agreement in Slovakia

AI SummaryClose X

ProBiotix Health plc has announced a new partnership with iProbio in Slovakia to supply its patented probiotic strain LPLDL® for a new cardiometabolic health food supplement called CARDIObiom+®. This product, developed by iProbio, aims to address the significant rates of cardiovascular disease and hypercholesterolaemia in Slovakia, with cardiovascular disease mortality being approximately 50% higher than the EU average and hypercholesterolaemia affecting around 49% of adults. CARDIObiom+® combines LPLDL® with other ingredients to support cholesterol and metabolic balance, and will initially be distributed in Slovakia through iProbio's e-commerce channel, with plans for expansion into pharmacies, health food stores, and further into the Czech Republic and other Central European markets.

Disclaimer*

UK 100

Latest directors dealings